Reduced Pulsatility Induces Periarteritis in Kidney: Role of the Local Renin-Angiotensin System

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 1, 2008, Pages 150-158

  Ootaki, Chiyo ^a   Yamashita, Michifumi ^b   Ootaki, Yoshio ^a   Kamohara, Keiji ^a   Weber, Stephan ^a   Klatte, Ryan S ^a   Smith, William A ^a   Massiello, Alex L ^a   Emancipator, Steven N ^b   Golding, Leonard A R ^a   Fukamachi, Kiyotaka ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL HEART; AUTOPSY; CALF (BOVINE); CONTROLLED STUDY; HEART ASSIST DEVICE; HEART RATE; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KIDNEY FUNCTION; MALE; MORPHOMETRICS; NONHUMAN; PERIARTERITIS; PRIORITY JOURNAL; PULSATILITY INDEX; PULSE PRESSURE; RENAL ARTERY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; STATISTICAL ANALYSIS;

ANGIOTENSIN II; ANIMALS; ARTERITIS; CATTLE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; NEPHRITIS; PEPTIDYL-DIPEPTIDASE A; PULSATILE FLOW; RECEPTORS, ANGIOTENSIN; RENAL ARTERY; RENIN-ANGIOTENSIN SYSTEM;

EID: 46049108137     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.12.023     Document Type: Article

References (34)

1. Nishimura T., Tatsumi E., Takaichi S., Taenaka Y., Wakisaka Y., Nakatani T., et al. Prolonged nonpulsatile left heart bypass with reduced systemic pulse pressure causes morphological changes in the aortic wall. Artif Organs 22 (1998) 405-410
2. Kihara S., Litwak K.N., Nichols L., Litwak P., Kameneva M.V., Wu Z., et al. Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist. Ann Thorac Surg 75 (2003) 178-183
3. Leung P.S. The peptide hormone angiotensin II: its new functions in tissues and organs. Curr Protein Pept Sci 5 (2004) 267-273
4. Kim S., and Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52 (2000) 11-34
5. Dostal D.E., and Baker K.M. The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?. Circ Res 85 (1999) 643-650
6. Davisson R.L., Oliverio M.I., Coffman T.M., and Sigmund C.D. Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 106 (2000) 103-106
7. Wagner J., Jan Danser A.H., Derkx F.H., de Jong T.V., Paul M., Mullins J.J., et al. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 80 (1996) 159-163
8. Leung P.S., Wong T.P., Lam S.Y., Chan H.C., and Wong P.Y. Testicular hormonal regulation of the renin-angiotensin system in the rat epididymis. Life Sci 66 (2000) 1317-1324
9. Gomez R.A., Lynch K.R., Chevalier R.L., Wilfong N., Everett A., Carey R.M., et al. Renin and angiotensinogen gene expression in the maturing rat kidney. Am J Physiol 254 (1988) 582-587
10. Ochiai Y., Golding L.A., Massiello A.L., Medvedev A.L., Horvath D.J., Gerhart R.L., et al. Cleveland Clinic CorAide blood pump circulatory support without anticoagulation. ASAIO J 48 (2002) 249-252
11. Fukamachi K., Horvath D.J., Massiello A.L., Ootaki Y., Kamohara K., Akiyama M., et al. Development of a small implantable right ventricular assist device. ASAIO J 51 (2005) 730-735
12. Weber S., Kamohara K., Klatte R.S., Luangphakdy V., Flick C., Chen J.F., et al. MagScrew TAH: an update. ASAIO J 51 (2005) xxxvi-xlvi
13. Amann K., Gharehbaghi H., Stephen S., and Mall G. Hypertrophy and hyperplasia of smooth muscle cells of small intramyocardial arteries in spontaneously hypertensive rats. Hypertension 25 (1995) 124-131
14. Nori M., Morigi M., Donadelli R., Aiello S., Foppolo M., Todeschini M., et al. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 76 (1995) 536-543
15. Helmlinger G., Berk B.C., and Nerem R.M. Calcium responses of endothelial cell monolayers subjected to pulsatile and steady laminar flow differ. Am J Physiol 269 (1995) 367-375
16. Vouyouka A.G., Powell R.J., Ricotta J., Chen H., Dudrick D.J., Sawmiller C.J., et al. Ambient pulsatile pressure modulates endothelial cell proliferation. J Mol Cell Cardiol 30 (1998) 609-615
17. Hernandez-Presa M., Bustos C., Ortego M., Tunon J., Renedo G., Ruiz-Ortega M., et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95 (1997) 1532-1541
18. Ruiz-Ortega M., Bustos C., Hernandez-Presa M.A., Lorenzo O., Plaza J.J., and Egido J. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 161 (1998) 430-439
19. Geisterfer A.A.T., Peach M.J., and Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62 (1988) 749-756
20. Powell J.S., Clozel J.P., Muller R.K., Kuhn H., Hefti F., Hosang M., et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245 (1989) 186-188
21. Campbell-Boswell M., and Robertson Jr. A.L. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 35 (1981) 265-276
22. Rieder M.J., Carmona R., Krieger J.E., Pritchard Jr. K.A., and Greene A.S. Suppression of angiotensin-converting enzyme expression and activity by shear stress. Circ Res 80 (1997) 312-319
23. Litwak K.N., Kihara S., Kameneva M.V., Litwak P., Uryash A., Wu Z., et al. Effects of continuous flow left ventricular assist device support on skin tissue microcirculation and aortic hemodynamics. ASAIO J 49 (2003) 103-107
24. Peach M.J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57 (1997) 313-370
25. Reid I.A., Morris B.J., and Ganong W.G. The renin-angiotensin system. Annu Rev Physiol 40 (1978) 377-410
26. Nafz B., Berthold H., Ehmke H., Hackenthal E., Kirchheim H.R., and Persson P.B. Flow versus pressure in the control of renin release in conscious dogs. Am J Physiol 273 (1997) 200-205
27. Rubanyi G.M., Romero J.C., and Vanhoutte P.M. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250 (1986) 1145-1149
28. Hutcheson I.R., and Griffith T.M. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow. Am J Physiol 261 (1991) 257-262
29. Nakano T., Tominaga R., Nagano I., Okabe H., and Yasui H. Pulsatile flow enhances endothelium-derived nitric oxide release in the peripheral vasculature. Am J Physiol Heart Circ Physiol 278 (2000) 1098-1104
30. Olson S., Oeckler R., Li X., Du L., Traganos F., Zhao X., et al. Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor. Am J Physiol Lung Cell Mol Physiol 287 (2004) 559-568
31. Ankersmit H.J., Wieselthaler G., and Moser B. Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump. J Thorac Cardiovasc Surg 123 (2002) 557-561
32. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
33. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
34. Cohn J.N., and Tognoni G. Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345 (2001) 1667-1675